Guardant Health revenue and financials
$170.69Change from previous close: −8.83%Absolute change: −$16.53
In the fiscal year ended December 2025, Guardant Health reported revenue of $982.02M (+32.88% year over year). The net loss was $416.28M.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +32.88%
- 2025 vs 2024
- Net margin
- -42.4%
- 2024: -59.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -185 | -240 | -325 | -309 | -209 | -104 | -47.1 | -72.2 | -72.2 | -36.7 |
| Depreciation and amortization | 39.7 | 42.4 | 42.9 | 36.0 | 22.3 | 16.1 | 11.4 | 7.1 | 5.2 | 3.7 |
| Capital expenditure | -48.3 | -35.1 | -20.5 | -77.5 | -75.0 | -36.2 | -18.7 | -20.2 | -6.7 | -1.8 |
| Investing cash flow | -627 | -261 | 840 | 150 | -63.2 | — | — | — | — | — |
| Financing cash flow | 671 | -1.0 | 477 | -189 | -66.8 | — | — | — | — | — |
| Share repurchases | -45.0 | 0.0 | 0.0 | -7.9 | -83.8 | 0.0 | 0.0 | -0.2 | -7.2 | -0.1 |
| Debt issued | 403 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — |
| Debt repaid | — | — | — | -0.1 | -0.1 | — | — | — | — | — |
| Effect of exchange rates | 0.5 | -1.8 | -0.9 | -1.6 | -1.7 | — | — | — | — | — |
| Net change in cash | -140 | -504 | 992 | -350 | -341 | — | — | — | — | — |
| Free cash flow | -233 | -275 | -345 | -387 | -284 | — | — | — | — | — |
| Levered free cash flow | -88.1 | -149 | -181 | -296 | -123 | — | — | — | — | — |